Posts Tagged ‘prevention’

Lise Alschuler, Naturopathic Physician, Discusses Prevention and Treatment of Cancer

Sunday, December 20th, 2015

LiseHeadshotStripedShirtLise Alschuler is a naturopathic doctor with board certification in naturopathic oncology and has been practicing since 1994. She graduated from Brown University with an undergraduate degree in Medical Anthropology and received a doctoral degree in naturopathic medicine from Bastyr University. Dr. Alschuler is past-President of the American Association of Naturopathic Physicians and a founding board member and current President of the Oncology Association of Naturopathic Physicians. She also currently serves as President Emeritus on the board of the Naturopathic Post-Graduate Association. Dr. Alschuler works as an independent consultant in the area of practitioner and consumer health education. She is the Executive Director of TAP integration, a nonprofit educational resource for integrative practitioners. She maintains a naturopathic oncology practice out of Naturopathic Specialists , based in Scottsdale AZ. Previously, she was the department head of naturopathic medicine at Midwestern Regional Medical Center – Cancer Treatment Centers of America. She was also the clinic medical director and botanical medicine chair at Bastyr, as well she was on the faculty of Southwest College of Naturopathic Medicine. The American Association of Naturopathic Physicians recognized Dr. Alschuler in 2014 as Physician of the Year. She also received an honorary degree from the Canadian College of Naturopathic Medicine and the Joseph Pizzorno Founders award from Bastyr University in the same year.

Dr. Alschuler is the co-author of The Definitive Guide to Cancer and The Definitive Guide to Thriving After Cancer. She co-created, and co-hosts a radio show, Five To Thrive Live! on the Cancer Support Network about living more healthfully in the face of cancer. She calls Tucson AZ and Chicago, IL home. Learn more at

Dr Rich Snyder (Kidney Disease) and Dr Larry Hoberman (probiotics) Interviewed.

Sunday, October 25th, 2015

Snyder-RichardMy first guest, Dr Rich Snyder is an osteopathic physician board certified in Internal Medicine and Nephrology (the study of kidney disease). His areas of specialization include kidney disease, high blood pressure, adrenal health and medical education. He is Associate Professor of Clinical Medicine at Temple University School of Medicine and Clinical Professor of Medicine at the Philadelphia College of Osteopathic Medicine. He is the author of five books including Adrenal Fatigue For Dummies and What You Must Know About Kidney Disease: A Practical Guide For Using Conventional and Complementary Treatments. He is also the author of What You Need to Know About Dialysis: The Secret to Surviving and Thriving on Dialysis and is also the High Blood Pressure Expert on

L HobermanMy second guest, Board Certified Gastroenterologist Lawrence Hoberman, MD, is the creator of EndoMune Advanced Probiotic and founder of Medical Care Innovations. He has spent more than 40 years practicing medicine and is board certified in both Internal Medicine and Gastroenterology. Frustrated by the lack of options to treat his patients suffering from Irritable Bowel Disease (IBD) in the early 2000s, Dr. Hoberman met with a PhD microbiologist to identify a combination of bacteria that might work to destroy the harmful bacteria living in the intestines, improving and maintaining the health of adults. The result is the development of his own effective probiotic supplement: EndoMune Advanced Probiotic.
Dr. Hoberman currently sees patients as a part of a health and wellness practice that stresses preventative medicine. He is in practice at Health by Design, located in San Antonio, Texas. He is available for speaking engagements about digestive health and the benefits of probiotics and has spoken at several conferences. More information is available at:

Listen to the Interview Below:




Can Coffee Help Prevent Obesity?

Wednesday, November 26th, 2014


A new study published in Pharmecutical Research concluded that a chemical commonly found in coffee may help prevent some of the damaging effects of obesity. Specifically, chlorogenic acid (CGA) found in coffee significantly reduces insulin resistance and accumulation of fat in the livers of mice who were fed a high fat diet. This compound that is found in great abundance in coffee is also found in fruits and vegetables like apples, pears, tomatoes and blueberries.

Two side effects of obesity in addition to weight geinare increased insulin resistance and the accumulation of fat in the liver that can lead to diabetes and poor liver function.  To test the effects of CGA a group of mice were fed a high fat iet for 15 wqeeks and were also injected with a CGA solution twice weekly. Findings showed that the CGA not only effectively prevented weight gaij, but also helped maintaihn normal blood pressure and healthy liver composition. The researchers said “CGA is a powerful antioxidant that reducesinflammation….A lot of evidence suggests that obesity-related diseases are caused by chronic inflammation. so if we can control that, we can hopefully ofset some of the negative effects of excessive weight gain.”

Can vitamin A assist in cancer prevention?

Wednesday, April 9th, 2014

logo1267406_mdResearch published recently in the International Journal of Oncology concluded that a derivative of vitamin A known as retinoic acid that is found in carrots and sweet potatoes helps pre-cancer cells revert back to normal cells. The researchers exposed four types of breast cells to different concernatrations of retinoic acid including normal, precancerous, cancerous, and fully aggressive cancer cells. They noted that precancer cells began to look like normal cells in shape but also changed their genetic signatyure back to normal. There were 443 genes in the precancer cells that were either up or down regulated on their way to becoming cancerous and that changed back to normal. The researcher said “we were able to see this effect of retinoic acid because we were looking at four distinct stages of breast cancer. However, the cells that were fully cancerous did not respond to the retinoic acid suggesting that there may be a small window of opportunity for the compound to help in preventing cancer progression. In addition, they found that only one concentration of the retinoic acid (about one micro Molar) produced the anti-cancer effect. They found that lower doses produced no change and higher doses produced a smaller effect. Further research is planned.


Does Silica Pose a Risk of Lung Cancer?

Friday, December 20th, 2013





A new study published in CA: A Cancer Journal for Clinicians a researcher concluded that there are new developments in understanding the effects of silica and they call for action to reduce illnessand death from silica exposure at work including stronger regulations, heightened awareness and prevention and increased attention to early detection of silicosos and lung cancer using low dose CT scanning.

Some developments include publication of studies providing detailed exposure response data, enabling regulations based upon quantitative risk assessment and also studies that show those exposed to silica who do not have silicosis and who do not smoke still have increased rates of death from lung mortality.In additional low dose computer tomography scanning has proven to be an effective screening method for lung cancer and the author recommends this screening be offered to those exposed beginning at age 50 if they also have a 20 pack years of smoking.

The report says the low level silica exposure on beaches and in ambient air in general, does not seem to cause health effects. Rather it is the concentrated exposure occurring on the job, most often construction materials such as concrete, masonry. tile and rock.

The most effective methods for controlling occupational exposure is banning sandblasting, metal grinds for abrasive blasting, modifying procedures and equipment, and controlling dust transmission by using enclosures, air curtains, water spray, and ventilation techniques, and the use of personal protective equipment., .

Can Coffee Reduce the Risk of Liver Cancer?

Wednesday, October 30th, 2013

logo1267406_mdA new study published in Clinical Gastroenterology and Hepatology concluded coffee consumption reduces the risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, by about 40 percent. The researchers said “Our research confirmed past claims that coffee is good for your health, and particularly the liver.”

A meta-analysis of articles published between 1996 and 2012 was carried out and 16 high quality studies with a total of 3,153 cases was selected for analysis. There was consistency of results across studies, time periods, and populations but it was difficult to establish whether the association between coffee drinking and HCC found was causal or if the relationship was a result of patients with liver and digestive diseases voluntarily reducing their coffee intake. Researchers said “It remains unclear whether coffee drinking has an additional role in liver cancer prevention.” They continue on to say that the role of coffee consumption would be limited compared to what is available through current measures such as hepatitis B virus vaccination, control of hepatitis C virus transmission and reduction of alcohol drinking that in total an avoid more than 90 percent of primary liver cancers worldwide.

Can Lifestyle Factors Reduce the Risk of Esophageal Cancer?

Friday, April 12th, 2013

logo1267406_mdRecent news from the Seattle Barrett’s Esophagus Program  at the Fred Hutchinson Cancer Research Center in collaboration with Brigham & Women’s College and the University of California in San Francisco have shown that a systematic approach to early  cancer detection can boost five-year survival rates from about 15 percent to more than 80 percent. They  have also shown that modifiable lifestyle factors-from reducing obesity to quitting smoking–may also prevent progression of Barrett’s esophagus to esophageal cancer. Some of the ways to prevent this condition from progressing to esophageal cancer were identified and follow.

Earlier research in 2007 reported that people with the more aggressive form of Barrett’s may benefit gfrom preventive therapy with aspirin or other non steroidal anti-inflammatory drugs. Following Barrett’s patients over time they identified a cluster of 4 known cancer bio markers  in this group that increased their risk of developing esophageal cancer. They found that subjects with 3 or more of these bio markers who also used aspirin or other no0nsteroidal anti inflammatory drugs (NSAID’s)  had a 30 % chance of developing esophageal cancer after 10 years whereas those who did not use the aspirin had a 79% change of developing cancer with a decade. They believe aspirin and other non-steroidal inflammatory drugs may fight cancer by reducing chronic  inflammation. However, because this was a long term observational study and not a clinical trial they cannot recommend aspirin for people with Barrett’s and also advise that anyone wh uses them do so under medical direction because of the side effects such as g.i. bleeding.

Another study looked at Barrett’s and statin drugs for lowering cholesterol and found that various combinations of statin and/or NSAID’s used by patients with Barrett’s and and high grade dysplasia had a reduced risk of esophageal cancer when compared with those who did not use these drugs.

This year they lo0ked at lifestyle and esophageal cancer and found that heavy smokers with Barrett’s were more than twice as likely to develop esophageal cancer than non-smokers with Barrett’s. They also found that obesity especially belly fat, was more strongly associated with the progression of Barrett’s to esophageal cancer.

They also offered suggestions for managing the symptoms of chronic acid reflux that is a risk factor for Barrett’s. These included smoking cessation, keeping weight down, getting regular exercise, eating a diet rich in fruit and vegetables, refrain from eating four hours before retiring, elevate the head of your bed if you have heart burn, and take antacids for occasional heartburn and see you doctor if you have frequent heartburn or if over the counter medications do not help.

Can the Common Aspirin Lower the Risk of Melanoma?

Friday, March 22nd, 2013

logo1267406_mdA new study published early online in Cancer concluded that women who take aspirin have a reduced risk of developing melanoma, and the longer they take it, the lower the risk. It seems possible that the anti-inflammatory effects of aspirin may help protect against melanoma.

As part of the women’s Health Initiative researchers observed women between ages 50 and 79 for an average of 12 years and determined which developed cancer. At the beginning of observations women were asked medications being taken, foods they ate, and activities they performed.

They found that of the 59,806 Caucasian women included those who took the most aspirins were less likely to develop melanoma skin cancer during the twelve years in relation to those who did not take aspirins. Overall women who used aspirin has a 21% lower risk of melanoma and each incremental increase in duration of aspirin use (less than one year of use, one to four years of use, and five or more years of use) was associated with an 11% lower risk of melanoma. Consequently, women who used aspirin for five or more years had a 30% lower risk for melanoma than women who did not use aspirin. Differences in pigmentation, tanning practices, sunscreen use, and other factors that may affect skin cancer were controlled for. The researcher concluded that “Aspirin works by reducing inflammation and this may be why using aspirin may lower your risk of developing melanoma. “

Can Omega-3s Inhibit Breast Cancer Tumor Growth?

Wednesday, February 27th, 2013

logo1267406_mdA new study published in the Journal of Nutritional Biochemistry concluded that a lifetime diet of omega-3 fatty acids can inhibit breast cancer tumors by 30 per cent. The researchers said “We show that lifelong exposure to omega-3s has a beneficial role in disease prevention–in this case, breast cancer prevention.  What’s important is that we have proven that omega-3s are the driving force and not something else.”

In the study, researchers created a novel transgenic mouse that both produces omega-3 fatty acids and develops aggressive mammary tumors. The researchers compared these mice to others genetically modified only to develop aggressive mammary tumors. Thus, researchers had a purely genetic approach to determine effect of  lifelong exposure to omega-3s on development of mammary tumors. Mice producing omega -3s developed only two thirds as many tumors and the tumors were 30% smaller when compared to the tumor only group. Researchers concluded “The difference can be solely attributed to the presence of omega-3s in the transgenic mice.”

Interviews with Breast Cancer Survivors Carmelina Vargas (singer/songwriter) and Tamara St Johns (adjunct professor) Now Available.

Sunday, November 25th, 2012

My guests yesterday were Carmelina Vargas (left) and Tamara St John (right). Both are breast cancer survivors.

Carmelina is a singer/songwriter from Barahona, Dominican  Republic who lives in New York and has published singles and albums of her music. More information was presented earlier on this site.

Tamara has a masters in business and is an adjunct professor in southern California. More information was presented earlier on this site.

The Interviews follow: